Arvinas

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$17.08-$53.08
Market Cap
$1.2B
Shares Short
9M

Financials

See more
Revenue (12 Mos)
$161.1M
Revenue Growth (YoY)
196%
Gross Profit (12 Mos)
$161.1M
Diluted EPS
-$4.79

News

See more

Yahoo Finance • 9 days ago

2 Growth Stocks That Could Rocket Higher in the First Quarter of 2025

Yahoo Finance • 7 months ago

Milestone Pharmaceuticals Refreshes Board of Directors

Yahoo Finance • 12 months ago

Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer

Yahoo Finance • last year

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

About

CEO
Dr. John G. Houston Ph.D.
CFO
Mr. Andrew R. Saik
Address
5 Science Park, New Haven, CT, United States, 06511
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
445